Patrocinado
Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
Postado
AstraZeneca is set to invest $50 billion in the U.S., featuring a large manufacturing plant in Virginia, marking its biggest manufacturing investment. This move aligns with the company's expectation that 50% of its revenue will come from the U.S. by 2030. The decision comes amid rising tariff pressures from the Trump administration, aiming to bolster domestic drug supply chains.
Pesquisar
Categorias
- National
- International
- Business
- Technology
- Health
- Educação
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leia mais
IND vs ENG: Stokes breaks bowling record as England push for series win
Ben Stokes showcased his unwavering commitment to England by surpassing his previous record for...
Spirit of the game row: DK defends Gill, shuts down Nasser - 'The issue was ...'
Shubman Gill recently criticized England's "spirit of the game" following a delay in their...
Top stocks to buy today: Stock recommendations for July 24, 2025 - check list
Top stock market recommendations: Aakash K Hindocha suggests a consolidation phase for Nifty...
Economic Digest: Nepal’s Business News in a snap
KATHMANDU: Economic Digest offers a concise yet comprehensive overview of significant business...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Portuguese (Brazil)
